• More Patients, More Revenue, but Less Rush. How? More Patients, More Revenue, but Less Rush. How? Doctors may think the only way to increase revenue is to add services, do more marketing, and change their practice. But there are ways to make more money by adapting what you're already doing. Here's how.
  • Doctors and Marriage: Should You Have a Prenup? Doctors and Marriage: Should You Have a Prenup? Love is powerful, yet marriage always involves some element of risk. Can you protect your finances and your practice in the event of a divorce and still start off a marriage on the right foot?
  • A Fierce but Effective Way to Combat Accounts Receivable A Fierce but Effective Way to Combat Accounts Receivable If A/R is mounting and some of it is long overdue, your current staff and billers might not make much headway. You need a tactical way to attack the problem.
  • New AMA Head on Membership, the ACA, and Medicine's Future New AMA Head on Membership, the ACA, and Medicine's Future   Dr. James Madara, of the American Medical Association, gives a candid interview on the nation's largest physician organization and whether it has any regrets about supporting the Affordable Care Act.
  • Can a Hospital Say, 'Only Thin Doctors Can Work Here'? Can a Hospital Say, 'Only Thin Doctors Can Work Here'?   A Texas hospital refuses to hire overweight staff, including doctors and nurses. Is this ethical -- or sensible? A leading bioethicist gives his take on the situation.
 

HIV/AIDS News
 – From Medscape Medical News, Reuters and more

  • U.S. HIV Aid Has Prevented 741,000 Deaths: Study U.S. HIV Aid Has Prevented 741,000 Deaths: Study The United States foreign aid program that sends billions of dollars to African countries for HIV treatment and prevention has cut the number of people dying for any reason in those nations.
  • FDA Panel Recommends First Drug for HIV Prevention FDA Panel Recommends First Drug for HIV Prevention The US Food and Drug Administration's Antiviral Drugs Advisory Committee has recommended approval of Gilead Science's Truvada for preexposure prevention of sexually acquired HIV-1 infection.
 

HIV/AIDS Perspectives

  • Global Gonorrhea: Problems on the Horizon Global Gonorrhea: Problems on the Horizon   Paul G. Auwaerter, MD, describes recent reports about antimicrobial resistance and gonorrhea that are very disturbing. What does this mean for the treating clinician?
  • Hepatitis G Virus (GBV-C): What We Know So Far Hepatitis G Virus (GBV-C): What We Know So Far The hepatitis G virus, known as GBV-C, seems to be well tolerated and could be a silver lining for patients with HIV, yet it increases the risk for non-Hodgkin lymphoma.
 

Medscape Collaborations

 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.